Annual EBITDA
$93.30M$30.10M+47.63%
Summary
- Current Value
- As of today, VREX annual EBITDA is $93.30M, up +47.63% on
- Historical Performance
- VREX annual EBITDA is down -24.51% over the past 3 years, and up +322.17% over the past 5 years
- All-Time High Comparison
- VREX annual EBITDA is currently -49.87% below its historical high of $186.10M set on
- 3-Year Low Comparison
- VREX annual EBITDA is +47.63% above its 3-year low of $63.20M reached on
- Sector Comparison
- VREX annual EBITDA is higher than 86.26% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $93.30M | +47.6% | -24.5% | +322.2% | -48.7% | |
| Quarterly EBITDA | $26.30M | +50.3% | -23.6% | +484.4% | -11.7% | |
| TTM EBITDA | $93.30M | +47.6% | -25.5% | +348.6% | +213.1% | |
| Price | $13.98 | +2.8% | -32.7% | -27.8% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $844.60M | +4.1% | -1.7% | +14.4% | +26.1% | |
| Annual EPS | -$1.70 | -42.0% | -333.1% | -13.8% | -159.5% | |
| $66.10M | +105.9% | -26.6% | +479.9% | -61.5% | ||
| Annual Net Income | -$69.90M | -44.7% | -326.9% | -21.8% | -163.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $123.60M | N/A | -24.5% |
| 5Y | $123.60M | -24.5% | |
| All | $186.10M | -49.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $63.20M | +47.6% | |
| 5Y | $22.10M | N/A | +322.2% |
| All | $22.10M | +322.2% |
EBITDA History
FAQ
What is the current annual EBITDA of VREX?
As of today, VREX annual EBITDA is $93.30M
What is 1-year change in VREX annual EBITDA?
VREX annual EBITDA is up +47.63% year-over-year
What is 3-year change in VREX annual EBITDA?
VREX annual EBITDA is down -24.51% over the past 3 years
How far is VREX annual EBITDA from its all-time high?
VREX annual EBITDA is currently -49.87% below its historical high of $186.10M set on September 30, 2014
How does VREX annual EBITDA rank versus sector peers?
VREX annual EBITDA is higher than 86.26% of companies in Healthcare sector
When is VREX next annual earnings release?
As of today, the next annual earnings release for VREX has not been scheduled
Quarterly EBITDA
$26.30M$6.30M+31.50%
Summary
- Current Value
- As of today, VREX quarterly EBITDA is $26.30M, up +31.50% on
- Historical Performance
- VREX quarterly EBITDA is up +50.29% year-over-year, and down -23.55% over the past 3 years
- All-Time High Comparison
- VREX quarterly EBITDA is currently -34.25% below its historical high of $40.00M set on
- 3-Year Low Comparison
- VREX quarterly EBITDA is +103.88% above its 3-year low of $12.90M reached on
- Sector Comparison
- VREX quarterly EBITDA is higher than 83.02% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $26.30M | +31.5% | +50.3% | -23.6% | +484.4% | |
| Annual EBITDA | $93.30M | – | +47.6% | -24.5% | +322.2% | |
| TTM EBITDA | $93.30M | +10.4% | +47.6% | -25.5% | +348.6% | |
| Price | $13.98 | +16.3% | +2.8% | -32.7% | -27.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $228.90M | +12.8% | +11.3% | -1.1% | +34.6% | |
| Quarterly EPS | $0.29 | +113.6% | +123.4% | -8.9% | +144.6% | |
| $19.60M | +48.5% | +79.8% | -25.5% | +517.0% | ||
| Quarterly Net Income | $12.20M | +113.7% | +123.9% | -7.6% | +148.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $28.70M | -8.4% | |
| 3Y | $34.10M | -22.9% | |
| 5Y | $35.80M | -26.5% | |
| All | $40.00M | -34.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $18.30M | N/A | +43.7% |
| 3Y | $12.90M | +103.9% | |
| 5Y | $12.90M | +103.9% | |
| All | -$12.50M | +310.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of VREX?
As of today, VREX quarterly EBITDA is $26.30M
What is VREX quarterly EBITDA most recent change?
VREX quarterly EBITDA was up +31.50% on September 1, 2025
What is 1-year change in VREX quarterly EBITDA?
VREX quarterly EBITDA is up +50.29% year-over-year
How far is VREX quarterly EBITDA from its all-time high?
VREX quarterly EBITDA is currently -34.25% below its historical high of $40.00M set on September 29, 2017
How does VREX quarterly EBITDA rank versus sector peers?
VREX quarterly EBITDA is higher than 83.02% of companies in Healthcare sector
When is VREX next earnings release?
The next earnings release for VREX is on
TTM EBITDA
$93.30M$8.80M+10.41%
Summary
- Current Value
- As of today, VREX TTM EBITDA is $93.30M, up +10.41% on
- Historical Performance
- VREX TTM EBITDA is up +47.63% year-over-year, and down -25.54% over the past 3 years
- All-Time High Comparison
- VREX TTM EBITDA is currently -28.56% below its historical high of $130.60M set on
- 3-Year Low Comparison
- VREX TTM EBITDA is +47.63% above its 3-year low of $63.20M reached on
- Sector Comparison
- VREX TTM EBITDA is higher than 83.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $93.30M | +10.4% | +47.6% | -25.5% | +348.6% | |
| Annual EBITDA | $93.30M | – | +47.6% | -24.5% | +322.2% | |
| Quarterly EBITDA | $26.30M | +31.5% | +50.3% | -23.6% | +484.4% | |
| Price | $13.98 | +16.3% | +2.8% | -32.7% | -27.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $844.60M | +2.8% | +4.1% | -1.7% | +14.4% | |
| TTM EPS | -$1.73 | +47.1% | -44.7% | -335.1% | -18.1% | |
| $66.10M | +15.2% | +105.9% | -27.9% | +451.6% | ||
| TTM Net Income | -$69.90M | +47.5% | -44.7% | -326.9% | -23.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $93.30M | at high | |
| 3Y | $121.90M | N/A | -23.5% |
| 5Y | $130.60M | -28.6% | |
| All | $130.60M | -28.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $68.60M | N/A | +36.0% |
| 3Y | $63.20M | +47.6% | |
| 5Y | $21.50M | N/A | +333.9% |
| All | $20.80M | +348.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of VREX?
As of today, VREX TTM EBITDA is $93.30M
What is VREX TTM EBITDA most recent change?
VREX TTM EBITDA was up +10.41% on September 1, 2025
What is 1-year change in VREX TTM EBITDA?
VREX TTM EBITDA is up +47.63% year-over-year
How far is VREX TTM EBITDA from its all-time high?
VREX TTM EBITDA is currently -28.56% below its historical high of $130.60M set on March 1, 2022
How does VREX TTM EBITDA rank versus sector peers?
VREX TTM EBITDA is higher than 83.74% of companies in Healthcare sector
When is VREX next earnings release?
The next earnings release for VREX is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- VREX Official Website www.vareximaging.com
- VREX Profile on Yahoo Finance finance.yahoo.com/quote/VREX
- VREX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrex